BIOT5830 (Regulatory Landscape of Cell and Gene Therapies) course reviews and ratings at Northeastern (NEU). Compare professors with RateMyProfessor reviews.
Introduces the current state of regulatory approvals for cell and gene therapies. Focuses on the scientific and technical considerations for approval for such drugs in the United States, in Europe, and in other key global markets. Explores the scientific challenges in the context of regulatory approval of these products, as well as how the process differs from traditional biotherapeutic product approvals. Examines how these regulatory pathways are evolving with a specific emphasis on quality, efficacy, and safety throughout the product life cycle (manufacturing through commercialization).
Data updated October 2026.